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1. Introduction
There is broad consensus that increasedunderstanding about the
nature of the relationship between lymphomas and other co-
morbidities, particularly auto-immune and infectious conditions, is
likely to provide valuable insights into the natural history of these
lymphoproliferative disorders [1]. Immunosuppression, whether
related to HIV infection or drug treatment, such as that experienced
by renal transplant recipients, appears to be associated with a
modest increase in risk of Hodgkin lymphoma (HL) and a greater
increase in risk of certain types of non-Hodgkin lymphoma (NHL)
[2,3]. Whilst a few subtypes of lymphoma are thought to be related
to speciﬁc infections there is little evidence that this is true for the
majority, but there is some support for the notion that non-speciﬁc
infectious episodes several years prior to lymphoma diagnosis may
signal disease initiation and/or progression [4].
In order to investigate the potential association between
infectious and other immunological factors and subsequent
lymphoma risk we systematically abstracted primary-health care
medical records of patients enrolled in a UK lymphoma case–
control study. We report here on the role of clinically diagnosed
medical conditions (as recorded in primary care medical records)
in the two commonest subtypes of NHL (diffuse-large B-cell
lymphoma and follicular lymphoma) and HL.
2. Methods
Details of the UK population-based case–control study are
described elsewhere in detail [4,5]. Brieﬂy, cases comprised
patients newly diagnosed with lymphoma (non-HIV-related)
residing in pre-deﬁned geographic areas and newly diagnosed
with lymphoma before 65 years of age during 1998–2003.
Diagnoses were conﬁrmed pathologically and coded according
to the World Health Organisation Classiﬁcation [6]. For each case,
one age and sex matched control was randomly selected from
population registers. The overall response rate was 75% in cases
and 71% in controls, which compares favourably with similar
studies conducted elsewhere in the world [7].
The ability to access data from an individual’s primary care
records over their lifetime is a major feature of the UK National
Health Service (NHS). For this reason, at interview subjects were
asked to consent to access to their primary care records; and all of
the information contained therein for the 15 years prior to
diagnosis in cases (or pseudo-diagnosis in controls) was subse-
quently abstracted onto specially designed forms by trained
research staff. For each contact with primary care, the information
recorded included all illnesses diagnosed at each consultation by
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Background: Increased understanding of the relationship between lymphomas and co-morbidities is
likely to provide valuable insights into the natural history of these disorders. Methods: 761 Cases with
lymphoma (310 diffuse-large B-cell [DLBCL]; 226 follicular [FL]; and 225 Hodgkin [HL]) and 761
unaffected age and sex matched controls were recruited and their histories of infection and non-
infection diagnoses in primary care records were compared using negative binomial regression. Results:
No differences were observed between the infectious illness patterns of DLBCL and FL cases and their
matched controls over the 15 years preceding lymphoma diagnosis. Amarked excess of infectious illness
episodes was recorded for HL cases compared to their controls; evident at least a decade prior to HL
diagnosis. For non-infectious consultations an excess of case over control visits emerged 4–6 years
before DLBCL and FL diagnosis; no speciﬁc co-morbidity associations were found. No case–control
differences for non-infectious conditions were apparent for HL. Conclusion: There are substantial
variations in patterns of illness prior to diagnosis of the three lymphoma subtypes examined. The excess
of infectious diagnoses prior to HL may point to underlying immune abnormality, but there was no
suggestion of this for DLBCL and FL where a generalized excess of non-infectious conditions was evident.
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the patient’s general practitioner (GP, i.e. their primary care
physician), as well as all signs and symptoms with which they
presented at the time, as well as resultant referrals to hospital or
other specialist organizations, results of the investigations, and
details of medicines or other prescribed therapies. All such
contemporaneously recorded data were abstracted.
Data abstraction and data entry were structured around dated
‘events’. Disease and drug coding was done centrally by experi-
enced primary care research nurses, using a specially designed
computerised system embedded within the data entry pro-
gramme. Illnesses and symptoms were coded according to the
International Statistical Classiﬁcation of Diseases and Related
Health Problems tenth revision (ICD-10) [8], and drugs to a schema
based on the British National Formulary [9]. Strict quality control
procedures, including duplicate data entry of a proportion of
randomly selected records, were carried out throughout the study
period. Ethical approval for the study was granted by the United
Kingdom Multi-Regional Ethics Committee.
Primary care records were abstracted for 310 (97.5% of those
interviewed) diffuse-large B-cell lymphoma (DLBCL) case/control
matched pairs, 226 (99.1% of those interviewed) follicular
lymphoma pairs (FL) and 225 (94.9% of those interviewed)
Hodgkin lymphoma (HL) pairs. Matched case–control studies
are often analysed using logistic regression conditional on the
matched sets, using the case/control status as outcome and other
variables thought relevant to the outcome as explanatory
variables. However, in a 1-1 matched study, it is also possible to
consider the case/control status as an explanatory variable in a
regression that considers some other variable as outcome. This is
because matching produces a case set and a control set that are
nominally identical, as sets, with respect to thematching variables.
Of course, the magnitude of any regression coefﬁcients cannot be
directly generalized from the sample to the population, but any
qualitative difference between cases and controls remains valid.
In the present study, counts of visits to primary care (general
practitioner) resulting in infectious disease diagnoses and non-
infectious disease diagnoses permonthwere considered as separate
longitudinal outcomes and modelled with negative binomial
regression, using the number ofmonths before lymphomadiagnosis
(or pseudo-diagnosis), case control status and the interaction of
these two variables as explanatory variables. As the counts of visits
resulting in infectious diagnoses and in non-infectious diagnoses
could now be considered as longitudinal outcomes, care was taken
over the selection of the appropriate functional form for the time
before lymphoma diagnosis/pseudo-diagnosis. In the models pre-
sented here, time before diagnosis was used untransformed. In
addition, negative binomial generalized additive models (GAMs)
were ﬁtted [10] in order to investigate possible departures from
thesemodel assumptions.Where the results of generalized additive
modelling depart from the main analysis, the differences are
described below. In addition, each monthly count was treated as
being independent from any other monthly count after diagnostic
checks revealed evidence of only small levels of inter-monthly
correlation. As a diagnostic check of this assumption, robust
standard errors were calculated. In all cases these made negligible
differences to the analysis. Conﬁdence intervals based on robust
standard errors are presented in Appendix A.
Inspection of the raw counts bymonth indicated a considerable
inﬂation of diagnoses in the year before diagnosis/pseudo-
diagnosis with lymphoma. In order to avoid the effects during
this period from swamping effects earlier than this, the 12 months
prior to diagnosis/pseudo-diagnosis were omitted from the
models. All analyses were performed using STATA version 10.0
[11] and R version 2.9.2 [12] with the mgcv library used for the
ﬁtting of generalized additive models [10], the MASS library [13]
for negative binomial regression and the sandwich library [14,15]
for robust standard errors.
3. Results
Of the 761 cases with lymphoma, 310 had diffuse-large B-cell
lymphoma (DLBCL), 226 had follicular lymphoma (FL) and 225 had
Hodgkin lymphoma (HL). The median age at diagnosis and sex
distribution for each type is shown in Table 1, together with the
median number of visits for the different types of diagnoses made
by the primary care physician (general practitioner) in the 15 years
prior to diagnosis (including and excluding the year prior to
diagnosis) for each lymphoma subtype and for controls. Overall,
there were substantially more visits for non-infectious problems
than for infections, both among cases and among controls.
Raw counts of visits to primary care (general practitioner)
resulting in infectious andnon-infectious diagnoses in the 15 years
prior to diagnosis are shown for each subtype of lymphoma in Figs. 1
and2 (casesare in redandcontrols inblue). Forboth typesofprimary
care (general practitioner) diagnosis and for all subtypes of
lymphoma, the counts rise markedly in the year prior to diagnosis.
These data are modelled as described in Section 2 – excluding data
from the year prior to diagnosis– and the linear relationship of non-
infectious and infectious diagnoses in cases and controls is shown in
Figs. 3 and 4 for each subtype of lymphoma.Model coefﬁcients, 95%
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Table 1
General practitioner (GP) visits forQ3 infectious and non-infectious diagnoses.
Non-Hodgkin’s lymphoma Hodgkin’s lymphoma
Diffuse-large B-cell Follicular Cases N=225 Controls N=225
Cases N=310 Controls N=310 Cases N=226 Controls N=226
Age at diagnosis/pseudo-diagnosis (median years) 54.4 54.4 54.1 54.1 38.8 38.8
Male (%) 167(53.9) 167 (53.9) 102 (45.1) 102(45.1) 142 (63.1) 142 (63.1)
GP visits in the 15 years before diagnosis/pseudo-diagnosis
Infectious diagnosis
Total visits 2561 2361 1872 1760 2390 1920
Median per person 6 5 6 6 8 6
Non-infectious diagnosis
Total visits 19,535 17,387 16,839 14,729 12,037 10,589
Median per person 45 36 53.5 45 37 34
GP visits in the 15 years before diagnosis/pseudo-diagnosis (excluding visits in the year immediately before
Infectious diagnosis
Total visits 2228 2154 1712 1649 2194 1800
Median per person 5 5 5 5 7 6
Non-infectious diagnosis
Total visits 16,236 15,825 14,444 13,327 10,126 9694
Median per person 37.5 33 44.5 42 31 30
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Fig. 1. (a) Raw counts of number of visits for diagnosed infections by month before
diagnosis/pseudo-diagnosis for diffuse-large B-cell lymphoma. Cases are in red;
controls in blue. (b) Raw counts of number of visits for diagnosed infectionsQ2 by
month before diagnosis/pseudo-diagnosis for Follicular Lymphoma. Cases are in
red; controls in blue. (c) Raw counts of number of visits for diagnosed infections by
month before diagnosis/pseudo-diagnosis for Hodgkin lymphoma. Cases are in red;
controls in blue. (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of the article.)
Fig. 2. (a) Fitted models for number of visits for infections from the 12 months
before diagnosis/pseudo-diagnosis for diffuse-large B-cell lymphoma. Solid lines
denote ﬁtted models; dashed lines give 95% conﬁdence intervals. Cases are in red;
controls in blue. (b) Fitted models for number of visits for infections from the 12
months before diagnosis/pseudo-diagnosis for Follicular Lymphoma. Solid lines
denote ﬁtted models; dashed lines give 95% conﬁdence intervals. Cases are in red;
controls in blue. (c) Fitted models for number of visits for infections from the 12
months before diagnosis/pseudo-diagnosis for Hodgkin lymphoma. Solid lines
denote ﬁtted models; dashed lines give 95% conﬁdence intervals. Cases are in red;
controls in blue. (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of the article.)
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Fig. 3. (a) Raw counts of number of visits for diagnosed non-infections by month
before diagnosis/pseudo-diagnosis for diffuse-large B-cell lymphoma. Cases are in
red; controls inblue. (b) Raw counts of number of visits for diagnosed non-infections
by month before diagnosis/pseudo-diagnosis for Follicular Lymphoma. Cases are in
red; controls inblue. (c) Raw counts of number of visits for diagnosed non-infections
bymonthbeforediagnosis/pseudo-diagnosis forHodgkin lymphoma.Casesare in red;
controls inblue. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of the article.)
Fig. 4. (a) Fitted models for number of visits for non-infections from the 12 months
before diagnosis/pseudo-diagnosis for diffuse-large B-cell lymphoma. Solid lines
denote ﬁtted models; dashed lines give 95% conﬁdence intervals. Cases are in red;
controls in blue. (b) Fitted models for number of visits for non-infections from the
12 months before diagnosis/pseudo-diagnosis for Follicular Lymphoma. Solid lines
denote ﬁtted models; dashed lines give 95% conﬁdence intervals. Cases are in red;
controls in blue. (c) Fittedmodels for number of visits for non-infections from the 12
months before diagnosis/pseudo-diagnosis for Hodgkin lymphoma. Solid lines
denote ﬁtted models; dashed lines give 95% conﬁdence intervals. Cases are in red;
controls in blue. (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of the article.)
S. Crouch et al. / Cancer Epidemiology xxx (2010) xxx–xxx4
G Model
CANEP 224 1–6
Please cite this article in press as: Crouch S, et al. Illness patterns prior to diagnosis of lymphoma: Analysis of UKmedical records. Cancer
Epidemiology (2010), doi:10.1016/j.canep.2010.08.003
conﬁdence intervals and corresponding p-values may be found in
Appendix A.
Fig. 3 shows the ﬁtted models for counts of visits resulting in
infectious diagnoses among cases (the red line) and controls (the
blue line) for the models linear in the time variable. There is no
evidence of any difference between cases and controls in relation
to the number or pattern of visits resulting in infectious diagnoses
prior to the onset of DLBCL or FL. However, for HL, there is a clear
excess of clinically diagnosed infections that is evident for at least a
decade prior to lymphoma diagnosis. This case–control difference
reﬂects a general increase in a broad range of infections, and is not
due to any speciﬁc infection.
Fig. 4 shows the ﬁtted models for counts of visits resulting in
non-infectious diagnoses. Here there is clear evidence of a case–
control difference for both DLBCL and FL; the excess being evident
for between 4 and 6 years prior to lymphoma diagnosis. As for
infections and HL, detailed examination of the records revealed
that this association was non-speciﬁc in nature – with most visits
being associatedwith symptoms such as tiredness, generalmalaise
and depression. No differences for visits resulting in non-infectious
diagnoses were evident for HL.
4. Discussion
Our results demonstrate substantial variation in the patterns of
illness presenting to primary care physicians in the years
preceding diagnosis of the lymphoma subtypes examined here.
Excesses of visits resulting in infectious diagnoses were noted for
HL and of visits resulting in non-infectious diagnoses for DLBCL and
FL; in all cases the excesses were evident several years before
lymphoma was diagnosed.
Although there are some differences in detail, the regression
models with time before diagnosis untransformed and the GAMs
reveal similar broad qualitative differences between the histories
of visits for infectious diagnoses and for non-infectious diagnoses
of these three conditions. As far as the history of visits for infectious
diagnoses is concerned, there is little difference between cases and
controls in DLBCL and FL, but in HL there is a marked divergence
between cases and controls dating from asmuch as 10 years before
diagnosis. For the history of visits for non-infectious diagnoses,
patterns are more closely related. GAMs suggest divergence
between cases and controls for DLBCL and FL between 4 and 6
years prior to diagnosis, with little difference between cases and
controls prior to that divergence; no such effect was seen for HL. In
summary, differences in patterns of attendance at primary care
were evident between cases and controls (for years prior to
diagnosis), but also between those with different types of
lymphoma. The excess of visits resulting in infectious diagnoses
prior to diagnosis of HL may suggest underlying immune
abnormality, but we found little evidence of such an effect among
patients subsequently diagnosed either with DLBCL or with FL.
However, there is good evidence that infectious and inﬂammatory
process may mediate risk of other lymphoma subtypes that were
too rare to consider here, and larger population-based studies will
be required [16–18].
Large amounts of information on previous illnesses, including
infections, are routinely collected by medical practitioners working
in primary care. Although these data,which are principally collected
with theaimofdocumentingandmonitoringpatient care, havebeen
used in a limitedway in epidemiological studies their potentialwith
respect to describing disease trajectories has yet to be fully realised
[19–23]. A critical feature for aetiological and otherstudies – where
the sequence and timing of events isimportant – is that information
held ingeneralpractitioner records is collectedprior to thediagnosis
ofmalignancy and sohas the advantage of being unaffected by recall
and reporting bias [24].
Limitations of our study include its restricted age range (18–
65 years), comparatively small size, and lack of information on
other lymphoma subtypes [17]. With respect to the ﬁrst of these,
the median age at diagnosis of most lymphoproliferative
malignancies exceeds 70 years, with the sex-speciﬁc rates
varying with age (www.seer.cancer.gov; www.hmrn.org).
DLBCL, for example, is more common in men, with the age-
speciﬁc rates diverging as age increases; FL on the other hand is
marginally more common in women with rates converging as
age increases. By contrast, HL has a characteristic bimodal age
distribution with a slight predominance of women at younger
ages and of men at older ages – these patterns being reﬂective of
different HL subtypes, which unfortunately we could not
distinguish in the present dataset.
In conclusion, the different patterns of co-morbidity reported
here, taken together with the different descriptive patterns,
suggest different pathogenic mechanisms. Furthermore, the long
prodromes suggested by our data indicate that disease may be
present long before the diagnosis is made.
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Table A1
Model coefﬁcients, conﬁdence intervals and p-values.
Coefﬁcient 95% CI p-Value
Infections
DLBCL
Intercept 2.84 (2.74, 2.94)
Case/control 0.0108 (0.151, 0.129) 0.88
Months 3.11103 (4.08103, 2.14103) <106
Interaction 4.97104 (8.66104, 1.86103) 0.47
Follicular
Intercept 2.41 (2.30, 2.52)
Case/control 0.119 (0.0405, 0.278) 0.14
Months 1.34103 (2.48103, 2.03104) 0.02
Interaction 8.80104 (2.47103, 7.06104) 0.28
Hodgkin
Intercept 2.36 (2.25, 2.47)
Case/control 0.344 (0.203, 0.485) 1.72106
Months 1.06104 (9.13104, 1.12103) 0.84
Interaction 1.54103 (2.86103, 2.15104) 0.023
Non-infections
DLBCL
Intercept 4.97 (4.94, 5.01)
Case/control 0.138 (0.0895, 0.186) <106
Months 4.69103 (5.05103, 4.34103) <106
Interaction 1.34103 (1.85103, 8.19104) <106
Follicular
Intercept 4.90 (4.85, 4.94)
Case/control 0.123 (0.0637, 0.182) 4.5105
Months 5.83103 (6.26103, 5.40103) <106
Interaction 5.19104 (1.10103, 5.84105) 0.078
Hodgkin
Intercept 4.41 (4.37, 4.46)
Case/control 0.0683 (8.3103, 0.128) 0.026
Months 3.91103 (4.34103, 3.49103) <106
Interaction 2.85104 (9.33104, 3.63104) 0.39
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